Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres

BACKGROUND: Oral cladribine has been approved for the treatment of relapsing multiple sclerosis (MS) yet real-world evidence regarding its effectiveness and safety remains scarce. OBJECTIVE: To evaluate efficacy and safety outcomes of MS patients following induction of cladribine. METHODS: We evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeuffer, Steffen, Rolfes, Leoni, Hackert, Jana, Kleinschnitz, Konstanze, Ruck, Tobias, Wiendl, Heinz, Klotz, Luisa, Kleinschnitz, Christoph, Meuth, Sven G, Pul, Refik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795224/
https://www.ncbi.nlm.nih.gov/pubmed/33975489
http://dx.doi.org/10.1177/13524585211012227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795224/
https://www.ncbi.nlm.nih.gov/pubmed/33975489
http://dx.doi.org/10.1177/13524585211012227

Ejemplares similares